GBT Announces Participation at the 2019 Wedbush PacGrow Healthcare Conference.
ENPNewswire-August 7, 2019--GBT Announces Participation at the 2019 Wedbush PacGrow Healthcare Conference
(C)2019 ENPublishing - http://www.enpublishing.co.uk
Release date- 06082019 - SOUTH SAN FRANCISCO - Global Blood Therapeutics, Inc.(GBT) (NASDAQ: GBT) today announced that it will present at the 2019 Wedbush PacGrow Healthcare Conference in New York City on Tuesday, August 13, 2019, at 1:55 p.m. Eastern Time.
The presentation will be webcast live from GBT's website at www.gbt.com in the Investors section. A replay of the webcast will be archived and available for replay for one month following the event.
GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing two therapies for the potential treatment of sickle cell disease, including its late-stage product candidate, voxelotor, as an oral, once-daily therapy.
[Editorial queries for this story should be sent to firstname.lastname@example.org]
((Distributed via M2 Communications - http://www.m2.com))
|Printer friendly Cite/link Email Feedback|
|Date:||Aug 7, 2019|
|Previous Article:||GSK grants exclusive technology license for clinical-stage Ebola vaccines to Sabin Vaccine Institute.|
|Next Article:||Flexion Therapeutics Reports Second-Quarter 2019 Financial Results and Recent Business Highlights.|